Cargando…
TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling
In patients non-proliferative disseminated tumour cells (DTCs) can persist in the bone marrow (BM) while other organs (i.e. lung) present growing metastasis. This suggested that the BM might be a metastasis “restrictive soil” by encoding dormancy-inducing cues in DTCs. Here we show in a HNSCC model...
Autores principales: | Bragado, Paloma, Estrada, Yeriel, Parikh, Falguni, Krause, Sarah, Capobianco, Carla, Farina, Hernan G., Schewe, Denis M, Aguirre-Ghiso, Julio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006312/ https://www.ncbi.nlm.nih.gov/pubmed/24161934 http://dx.doi.org/10.1038/ncb2861 |
Ejemplares similares
-
Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion
por: Elderbroom, Jennifer L., et al.
Publicado: (2014) -
TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling
por: Tazat, Keren, et al.
Publicado: (2015) -
Betaglycan (TβRIII) is a Key Factor in TGF-β2 Signaling in Prepubertal Rat Sertoli Cells
por: Kudipudi, Pradeep K, et al.
Publicado: (2019) -
microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
por: Fang, Chi, et al.
Publicado: (2018) -
Immunoexpression of Transforming Growth
Factor Beta 3 (TGFβ3) and Its Receptor Type III (TGFβRIII) in Basal Cell Carcinomas
por: FLORESCU, D., et al.
Publicado: (2018)